Skip to main content
Top

Clinical and Translational Oncology

Issue 12/2014

Content (10 Articles)

Open Access Editorial

SEOM guidelines 2014: improving quality to increase its usefulness

P. Garrido, C. A. Rodríguez

Open Access Clinical Guides in Oncology

SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) 2014

R. Garcia-Carbonero, P. JImenez-Fonseca, A. Teulé, J. Barriuso, I. Sevilla

Open Access Clinical Guides in Oncology

Thyroid cancer: SEOM clinical guidelines

J. M. Trigo, J. Capdevila, E. Grande, J. Grau, P. Lianes

Open Access Clinical Guides in Oncology

SEOM clinical guidelines for the treatment of renal cell carcinoma

J. Bellmunt, J. Puente, J. Garcia de Muro, N. Lainez, C. Rodríguez, I. Duran

Open Access Clinical Guides in Oncology

SEOM guidelines on hydroelectrolytic disorders

R. De las Peñas, Y. Escobar, F. Henao, A. Blasco, C. A. Rodríguez

Open Access Clinical Guides in Oncology

SEOM Clinical guidelines for the treatment of metastatic prostate cancer

J. Cassinello, M. A. Climent, A. González del Alba, B. Mellado, J. A. Virizuela

Open Access Clinical Guides in Oncology

SEOM guideline in ovarian cancer 2014

A. Gonzalez-Martín, I. Bover, J. M. Del Campo, A. Redondo, L. Vidal

Open Access Clinical Guides in Oncology

SEOM guide to primary and secondary prevention of cancer: 2014

P. P. Segura, J. P. B. Fombella, B. P. Lorenzo, M. R. Martín, P. G. Lopez

Open Access Clinical Guides in Oncology

Clinical guide SEOM on venous thromboembolism in cancer patients

A. J. Muñoz Martín, C. Font Puig, L. M. Navarro Martín, P. Borrega García, M. Martín Jiménez

Open Access Clinical Guides in Oncology

Clinical guideline SEOM: cancer of unknown primary site

R. Collado Martín, A. García Palomo, L. de la Cruz Merino, P. Borrega García, F. J. Barón Duarte

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine